Insights from 2023 SABCS


 

SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapine With Triple Antiemetic Therapy for Prevention of Highly Emetogenic Chemo-Induced Nausea & Vomiting in Solid Tumors"

59 views
February 28, 2024
Comments 0
Login to view comments. Click here to Login